本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kazia Therapeutics Limited

6.78
+0.22003.35%
盘后6.780.00000.00%19:56 EDT
成交量:4.42万
成交额:29.90万
市值:1,097.57万
市盈率:-0.27
高:6.94
开:6.53
低:6.42
收:6.56
52周最高:39.05
52周最低:2.86
股本:161.88万
流通股本:147.79万
量比:0.07
换手率:2.99%
股息:- -
股息率:- -
每股收益(TTM):-24.6667
每股收益(LYR):-33.8792
净资产收益率:-3891.64%
总资产收益率:-85.55%
市净率:-4.36
市盈率(LYR):-0.20

数据加载中...

2021/09/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]